Nutrition, Metabolism & Cardiovascular Diseases
Volume 22, Issue 2 , Pages 109-114 , February 2012

Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation

  • M. Phang

      Affiliations

    • Nutraceuticals Research Group, School of Biomedical Sciences & Pharmacy, 305C Medical Sciences Building, University of Newcastle, Callaghan, NSW 2308, Australia
    • Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW 2310, Australia
    • ,
  • A.J. Sinclair

      Affiliations

    • School of Exercise Science & Nutrition, Deakin University, Waurn Ponds, VIC 3220, Australia
    • Metabolic Research Unit, Deakin University, Waurn Ponds, VIC 3220, Australia
    • ,
  • L.F. Lincz

      Affiliations

    • Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, NSW 2298, Australia
    • ,
  • M.L. Garg

      Affiliations

    • Nutraceuticals Research Group, School of Biomedical Sciences & Pharmacy, 305C Medical Sciences Building, University of Newcastle, Callaghan, NSW 2308, Australia
    • Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW 2310, Australia
    • Corresponding Author InformationCorresponding author. Nutraceuticals Research Group, School of Biomedical Sciences & Pharmacy, 305C Medical Sciences Building, University of Newcastle, Callaghan, NSW 2308, Australia. Tel.: +61 2 4921 5647; fax: +61 2 4921 2028.

Received 13 January 2010 ,Revised 13 April 2010 ,Accepted 15 April 2010.

References 

  1. Agirbasli M. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract. 2005 Jan;59(1):102–106
  2. von Lewinski F, Riggert J, Paulus W. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?. J Stroke Cerebrovasc Dis. 2009 Mar–Apr;18(2):111–115
  3. Dockrell ME, Walker BR, Noon JP, Watt GC, Williams BC, Webb DJ. Platelet aggregation in young men with contrasting predisposition to high blood pressure. Am J Hypertens. 1999 Feb;12(2 Pt 1):115–119
  4. Lazarus SA, Bowen K, Garg ML. Tomato juice and platelet aggregation in type 2 diabetes. JAMA. 2004 Aug 18;292(7):805–806
  5. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J. 2006 Mar;27(6):647–654
  6. Grundt H, Nilsen DW. n-3 fatty acids and cardiovascular disease. Haematologica. 2008 Jun;93(6):807–812
  7. Gaudette DC, Holub BJ. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity. Lipids. 1990 Mar;25(3):166–169
  8. Nagakawa Y, Orimo H, Harasawa M, Morita I, Yashiro K, Murota S. Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man. A double blind study. Atherosclerosis. 1983 Apr;47(1):71–75
  9. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008 Mar;197(1):12–24
  10. von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest. 1985 Oct;76(4):1626–1631
  11. Archer SL, Green D, Chamberlain M, Dyer AR, Liu K. Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1119–1123
  12. Agren JJ, Vaisanen S, Hanninen O, Muller AD, Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4–5):419–421
  13. Nelson GJ, Schmidt PS, Bartolini GL, Kelley DS, Kyle D. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids. 1997 Nov;32(11):1129–1136
  14. Marckmann P, Bladbjerg EM, Jespersen J. Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3384–3391
  15. Phang M, Garg ML, Sinclair AJ. Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-Redefining platelet response to fish oils. Prostaglandins Leukot Essent Fatty Acids. 2009 Jul;81(1):35–40
  16. Cardinal DC, Flower RJ. The electronic aggregrometer: a novel device for assessing platelet behaviour in blood. J Pharmacol Methods. 1980;3:135–158
  17. Conquer JA, Holub BJ. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr. 1996 Dec;126(12):3032–3039
  18. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O, Uusitupa MI. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids. 1997 Jul;32(7):697–705
  19. Cheryk LA, Conquer JA, Holub BJ, Gentry PA. Docosahexaenoic acid and docosapentanoic acid incorporation into human platelets after 24 and 72 hours: inhibitory effects on platelet reactivity. Platelets. 1999 Jul;10(4):203–211
  20. von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest. 1985 Dec;76(6):2446–2450
  21. Seo J, Barhoumi R, Johnson AE, Lupton JR, Chapkin RS. Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. FASEB J. 2006 Apr;20(6):770–772
  22. Das UN. Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link?. (Burbank, Los Angeles County, Calif) Nutrition. 2002 Feb;18(2):178–188
  23. Bayon Y, Croset M, Daveloose D, Guerbette F, Chirouze V, Viret J, et al. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J Lipid Res. 1995 Jan;36(1):47–56
  24. Matsuda K, Mathur RS, Duzic E, Halushka PV. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol. 1993 Dec;265(6 Pt 1):E928–E934
  25. Matsuda K, Ruff A, Morinelli TA, Mathur RS, Halushka PV. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol. 1994 Sep;267(3 Pt 2):H887–H893
  26. Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995 Jun 1;91(11):2742–2747
  27. De Caterina R, Spiecker M, Solaini G, Basta G, Bosetti F, Libby P, et al. The inhibition of endothelial activation by unsaturated fatty acids. Lipids. 1999;34(Suppl.):S191–S194
  28. Eschen O, Christensen JH, De Caterina R, Schmidt EB. Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids. Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):180–185
  29. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 1996 Jul 1;98(1):36–42
  30. Ponthieux A, Herbeth B, Droesch S, Lambert D, Visvikis S. Age- and sex-related reference values for serum adhesion molecule concentrations in healthy individuals: intercellular adhesion molecule-1 and E-, P-, and L-selectin. Clin Chem. 2003 Sep;49(9):1544–1546
  31. Pawlosky R, Hibbeln J, Lin Y, Salem N. n-3 fatty acid metabolism in women. Br J Nutr. 2003 Nov;90(5):993–994[discussion 4–5]
  32. Thorngren M, Gustafson A. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet. 1981 Nov 28;2(8257):1190–1193
  33. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991 Aug;84(2):613–617
  34. Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005 Sep–Oct;45(5):581–597
  35. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, et al. Effects of purified eicosapentaenoic acid and docosahexenoic acid on platelet, fibrinolytic and vascular function in hypersensitive type 2 diabetic patients. Antherosclerosis. 2003;166(1):85–93

PII: S0939-4753(10)00113-4

doi: 10.1016/j.numecd.2010.04.012

Nutrition, Metabolism & Cardiovascular Diseases
Volume 22, Issue 2 , Pages 109-114 , February 2012

Article Tools

* Image Usage & Resolution